| Literature DB >> 32122944 |
Ashley L Marcinkiewicz1, Yi-Pin Lin2,3, Ilva Lieknina4, Xiuli Yang5, Patricia L Lederman1, Thomas M Hart1,6, Jennifer Yates1, Wen-Hsiang Chen7,8, Maria Elena Bottazzi7,8,9, Nicholas J Mantis1,3, Peter Kraiczy10, Utpal Pal5, Kaspars Tars4.
Abstract
The spirochete Borrelia burgdorferi sensu lato is the causative agent of Lyme disease (LD). The spirochetes produce the CspZ protein that binds to a complement regulator, factor H (FH). Such binding downregulates activation of host complement to facilitate spirochete evasion of complement killing. However, vaccination with CspZ does not protect against LD infection. In this study, we demonstrated that immunization with CspZ-YA, a CspZ mutant protein with no FH-binding activity, protected mice from infection by several spirochete genotypes introduced via tick feeding. We found that the sera from CspZ-YA-vaccinated mice more efficiently eliminated spirochetes and blocked CspZ FH-binding activity than sera from CspZ-immunized mice. We also found that vaccination with CspZ, but not CspZ-YA, triggered the production of anti-FH antibodies, justifying CspZ-YA as an LD vaccine candidate. The mechanistic and efficacy information derived from this study provides insights into the development of a CspZ-based LD vaccine.Entities:
Keywords: Borrelia; CspZ; Lyme disease; vaccine
Year: 2020 PMID: 32122944 PMCID: PMC7171238 DOI: 10.1128/IAI.00956-19
Source DB: PubMed Journal: Infect Immun ISSN: 0019-9567 Impact factor: 3.441